Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
Neuropharmacology
|
December 1, 1983
Effect of naloxone and morphine on dopamine agonist-induced stereotypy in rats and guinea pigs
J Feigenbaum, J Yanai, B Moon, et al.
Neuropsychobiology
|
January 1, 1984
Effect of naloxone on dopamine uptake and release in vitro in the striatum
J J Feigenbaum, J Yanai, C Iser, et al.
The International Journal of Neuroscience
|
January 1, 1983
The combined effect of quipazine and haloperidol on plasma prolactin release
J Feigenbaum, J Yanai, H L Klawans, et al.
Bulletin of the Los Angeles Neurological Societies
|
October 1, 1975
Myelopathy simulating spinal cord tumor
S M Wolf, J Keane, J Feigenbaum, et al.
European Journal of Pharmacology
|
October 4, 1989
Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoid
J J Feigenbaum, S A Richmond, Y Weissman, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
January 1, 1991
Nonpsychotropic synthetic cannabinoids as therapeutic agents
R Mechoulam, A Breuer, J J Feigenbaum, et al.
The International Journal of Neuroscience
|
February 1, 1987
Diethylstilbestrol counteracts barbiturate narcosis and hypothermia in male mice
R H Fishman, J J Feigenbaum, C Iser-Strenger, et al.
Progress in Neurobiology
|
January 1, 1983
The relative importance of dopamine and norepinephrine in mediating locomotor activity
R H Fishman, J J Feigenbaum, J Yanai, et al.
The International Journal of Neuroscience
|
January 1, 1983
Morphine may not produce true catalepsy
J J Feigenbaum, J Yanai, B H Moon, et al.
Pain
|
October 1, 1991
Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking properties
R Zeltser, Z Seltzer, A Eisen, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
Neuropharmacology
|
December 1, 1983
Effect of naloxone and morphine on dopamine agonist-induced stereotypy in rats and guinea pigs
J Feigenbaum, J Yanai, B Moon, et al.
Neuropsychobiology
|
January 1, 1984
Effect of naloxone on dopamine uptake and release in vitro in the striatum
J J Feigenbaum, J Yanai, C Iser, et al.
The International Journal of Neuroscience
|
January 1, 1983
The combined effect of quipazine and haloperidol on plasma prolactin release
J Feigenbaum, J Yanai, H L Klawans, et al.
Bulletin of the Los Angeles Neurological Societies
|
October 1, 1975
Myelopathy simulating spinal cord tumor
S M Wolf, J Keane, J Feigenbaum, et al.
European Journal of Pharmacology
|
October 4, 1989
Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoid
J J Feigenbaum, S A Richmond, Y Weissman, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
January 1, 1991
Nonpsychotropic synthetic cannabinoids as therapeutic agents
R Mechoulam, A Breuer, J J Feigenbaum, et al.
The International Journal of Neuroscience
|
February 1, 1987
Diethylstilbestrol counteracts barbiturate narcosis and hypothermia in male mice
R H Fishman, J J Feigenbaum, C Iser-Strenger, et al.
Progress in Neurobiology
|
January 1, 1983
The relative importance of dopamine and norepinephrine in mediating locomotor activity
R H Fishman, J J Feigenbaum, J Yanai, et al.
The International Journal of Neuroscience
|
January 1, 1983
Morphine may not produce true catalepsy
J J Feigenbaum, J Yanai, B H Moon, et al.
Pain
|
October 1, 1991
Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking properties
R Zeltser, Z Seltzer, A Eisen, et al.
Page
of 7